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Introduction. Antibodies against Chlamydia pneumoniae are associated with the progression of abdominal aortic aneu-
rysms (AAA), but cross-react with immunoglobulins in AAA walls indicating an autoimmune reaction.
Report. Of 82 men with a small AAA followed for 1e5 years, 17% (10e27%) had antibodies against immunoglobulin,
3.7% had antinuclear antibodies (ANA), 19.5% (11e30%) had antinuclear core antibodies (ANCA), 2.4% had anti-beta-
2-gpI IgG and 3,7% antibodies against cardiolipin.
The presence of antibodies against immunoglobulin and ANCA were not correlated with expansion rate; 2.61 and
2.76 mm/year, respectively, compared to 2.40 and 2.39 mm/year annually among those without such antibodies.
Discussion. Known autoantibodies are seldomly present in AAA and seem not to influence the progression of AAA.
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Recently, we published results showing that anti-
bodies against Chlamydia pneumoniae outer mem-
brane protein (OMP) purified from patients with
abdominal aortic aneurysms (AAA) react with OMP,
but we could not detect any sign of OMP in the wall
of AAAs, but other proteins e possibly immuno-
globulins e were cross-reacting with the anti-OMP
antibody.1
The correlation between antibodies against Cp and
the progression of small AAA2 strongly suggests
a pathogenetic role of the protein that caused the an-
tibodies to be produced. From the study, we cannot
conclude that this protein was OMP, or that another
protein with similar epitopes as OMP. The missing
presence of OMP suggests another protein to be
involved. The demonstrated potential cross-reaction
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reaction.
Consequently, we have analyzed serum samples
from our cohort of screen detected AAA for anti-
bodies against immunoglobulin and other known
autoantibodies in order to study the frequency of
autoantibodies in AAA and their correlation with
the expansion rate of AAA.3
Report
Serum from 82 men with a small AAA2 were con-
trolled annually for up till 5 years for expansion,
and their baseline serum samples were tested for var-
ious known autoantibodies at the only laboratory in
Denmark performing the tests routinely.
The median max. initial AAA-diameter: 32 mm.
Median follow up time was 4.11 years, and median
expansion rate was 2.44 mm/year. The interobserver
variation of the diameter measurements was 1.4 mm.4
The results are summarised in Table 1; the frequen-
cies of autoantibodies were limited; 17% (95% C.I.:
10e27%) had IgM and/or IgG antibodies against
14 S. Urbonavicius et al.Table 1. Presence of autoantibodies in a cohort of patients with small abdominal aortic aneurysms, and their association with mean
annual expansion rate
Autoantibodies Present N¼ 82 Frequency 95% C.I. Expansion rate
(mm/year)
P-value*
Ig against Immunoglogulin þ 13 15.9% 8.7e25.6% 2.67 0.68
 2.40
Antinuclear antibodies þ 3 3.7% 0.8e10.3% 3.86 0.18
 2.44
Anti nuclear core antibodies þ 16 19.5% 0.3e28.5% 3.01 0.49
 2.45
Anti-beta-2-gpI Immunoglobulin þ 2 2. 4% 0.3e8.5% 4.51 0.39
 2.47
Ig against cardiolipin þ 3 3.7% 0.8e10.3% 2.48 0.88
 2.58
*P-values by Wlicoxon’s rang sum test.immunoglobulin, 3.7% (0.8e10.3%) had antinuclear
antibodies (ANA), 19.5% (11e30%) had antinuclear
core antibodies (ANCA), 2.4% (0.3e8.5%) had anti-
beta-2-gpI IgG and 3,7% (0.8e10.3%) had IgM and/or
IgG antibodies against cardiolipin.
The presence of antibodies against immunoglobu-
lin and ANCA were not correlated with aneurysmal
progression rate; 2.67 and 3.01 mm/year, respectively,
compared to 2.40 (P¼ 0.68) and 2.45 (P¼ 0.49) mm/
year annually among those without such antibodies.
Discussion
Known autoantibodies, including antibodies against
immunoglobulin, are seldomly present in AAA and
seem not to influence the progression of AAA.EJVES Extra Vol 12, August 2006References
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